Most commonly known by their brand names, Trulicity (dulaglutide), Ozempic and Wegovy (semaglutide) and Saxenda and Victoza (liraglutide), GLP-1 agonists have been approved for use in management of type two diabetes and for weight loss
The RER (RER = vCO 2 /vO 2 ) was calculated from measured vO 2 and vCO 2 values
Available in 3mL and 10mL sizes with lot-coded traceability and tamper-evident packaging
Read more Learn why GLP-1 medications like Ozempic and Mounjaro may cause dizziness, plus practical strategies to manage this side effect safely
It is estimated that 1030% of individuals with NAFLD can be complicated by NASH and approximately 20% of individuals with NASH will progress to cirrhosis, hepatocellular carcinoma and/or liver failure
Trial populations, dosing schedules, and the level of behavioral support provided in trials often differ significantly from real-world telehealth conditions, and individual outcomes vary widely